Integrated Filing — IndAS



General information about company

Scrip Code 539785
NSE Symbol PDMJEPAPER
MSEI Symbol NOTLISTED
ISIN INE865T01018
Name of company PUDUMJEE PAPER PRODUCTS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 16-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 26-May-2025   13:00:00
End date and time of board meeting 26-May-2025   13:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-26
Indicate Company website link for updated RPT policy of the Company www.pudumjee.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1900800000 8090800000
Other income 50800000 209200000
Total income 1951600000 8300000000
2 Expenses
(a) Cost of materials consumed 1077400000 4427600000
(b) Purchases of stock-in-trade 20000000 71300000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -57700000 -119600000
(d) Employee benefit expense 148600000 590600000
(e) Finance costs 8600000 32100000
(f) Depreciation, depletion and amortisation expense 34700000 131000000
(f) Other Expenses
1 Fuel, Power & Water Expenses 287100000 1192400000
2 Net Foreign Exchange Loss/(Gain) 4200000 -2600000
3 Other Expenses 182100000 690000000
Total other expenses 473400000 1879800000
Total expenses 1705000000 7012800000
3 Total profit before exceptional items and tax 246600000 1287200000
4 Exceptional items 0 0
5 Total profit before tax 246600000 1287200000
6 Tax expense
7 Current tax 62100000 327500000
8 Deferred tax -4000000 2100000
9 Total tax expenses 58100000 329600000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 188500000 957600000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 188500000 957600000
17 Other comprehensive income net of taxes -41700000 5100000
18 Total Comprehensive Income for the period 146800000 962700000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 95000000 95000000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 5733800000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.99 10.09
Diluted earnings (loss) per share from continuing operations 1.99 10.09
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.99 10.09
Diluted earnings (loss) per share from continuing and discontinued operations 1.99 10.09
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. A Dividend for the year ended 31st March,2025 at the rate of Re. 0.60 per Equity share of Re. 1/- each amounting to Rs.569.70 lacs is recommended by the Board of Directors in their meeting held on 26th May 2025, subject to approval of the shareholders at the ensuing Annual General Meeting. n n2. The above financial results were reviewed and recommended by the Audit Committee and taken on record by the Board of Directors at their meeting held on 26th May 2025. n n3.The Statutory Auditors have carried out the audit for the year ended March 31, 2025. Figures for the quarter ended March 31, 2025 and March 31, 2024 are the balancing figures between audited figures in respect of the full financial year and published year to date figures upto the third quarter of the respective financial year. n n4.This statements has been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. n n5.The Company is not 'Large Corporate' as on 31st March, 2025 as per criteria provided in SEBI circular dated 26-11-2018. n n6.The figures for previous period have been recast and regrouped wherever necessary to conform to current period's presentations.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1419600000
Capital work-in-progress 276800000
Investment property 695700000
Goodwill 642500000
Other intangible assets 3300000
Intangible assets under development 100000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 203100000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 2200000
Total non-current financial assets 205300000
Deferred tax assets (net) 0
Other non-current assets 144900000
Total non-current assets 3388200000
2 Current assets
Inventories 1295600000
Current financial asset
Current investments 1294200000
Trade receivables, current 682800000
Cash and cash equivalents 354200000
Bank balance other than cash and cash equivalents 25500000
Loans, current 518500000
Other current financial assets 9400000
Total current financial assets 2884600000
Current tax assets (net) 32700000
Other current assets 33200000
Total current assets 4246100000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 7634300000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 95000000
Other equity 5733800000
Total equity attributable to owners of parent 5828800000
Non controlling interest
Total equity 5828800000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 89200000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 34700000
Total non-current financial liabilities 123900000
Provisions, non-current 399400000
Deferred tax liabilities (net) 273400000
Deferred government grants, Non-current 0
Other non-current liabilities 98200000
Total non-current liabilities 894900000
Current liabilities
Current financial liabilities
Borrowings, current 2600000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 18200000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 551000000
Total Trade payable 569200000
Other current financial liabilities 197200000
Total current financial liabilities 769000000
Other current liabilities 141600000
Provisions, current 0
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 910600000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 1805500000
Total equity and liabilites 7634300000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Paper 1834500000 7822800000
2 Hygine Products 158700000 578400000
Total Segment Revenue 1993200000 8401200000
Less: Inter segment revenue 92400000 92400000
Revenue from operations 1900800000 8090800000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Paper 206700000 1151300000
2 Hygine Products 14000000 56500000
Total Profit before tax 220700000 1207800000
i. Finance cost 8600000 8600000
ii. Other Unallocable Expenditure net off Unallocable income -34500000 -34500000
Profit before tax 246600000 1287200000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Paper 6020700000 6020700000
2 Hygine Products 105700000 105700000
Total Segment Asset 6126400000 6126400000
Un-allocable Assets 1507900000 1507900000
Net Segment Asset 7634300000 7634300000
4 Segment Liabilities
Segment Liabilities
1 Paper 1199200000 1199200000
2 Hygine Products 46300000 46300000
Total Segment Liabilities 1245500000 1245500000
Un-allocable Liabilities 560000000 560000000
Net Segment Liabilities 1805500000 1805500000
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Amount of items that will not be reclassified to profit and loss -49300000 3300000
Total Amount of items that will not be reclassified to profit and loss -49300000 3300000
2 Income tax relating to items that will not be reclassified to profit or loss -7600000 -1800000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -41700000 5100000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1287200000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 32100000
Adjustments for decrease (increase) in inventories 168500000
Adjustments for decrease (increase) in trade receivables, current 0
Adjustments for decrease (increase) in trade receivables, non-current 92400000
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -342800000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 131000000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -7900000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 44700000
Adjustments for interest income 112600000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -40300000
Other adjustments to reconcile profit (loss) -9100000
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -133400000
Net cash flows from (used in) operations 1153800000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 330100000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 823700000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 1800000
Purchase of property, plant and equipment 259200000
Proceeds from sales of investment property 52700000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 300000
Interest received 112600000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -257900000
Net cash flows from (used in) investing activities -349700000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 59300000
Repayments of borrowings 116200000
Payments of lease liabilities 21800000
Dividends paid 57000000
Interest paid 32100000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -167800000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 306200000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 306200000
Cash and cash equivalents cash flow statement at beginning of period 48000000
Cash and cash equivalents cash flow statement at end of period 354200000





Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 J M AGRAWAL & CO Yes 30-Sep-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Pudumjee Paper Product Limited Quality Tissue Converting Company Private Limited Group Company Sale of goods or services 1000000 Approved 63000 0 0
2 Pudumjee Paper Product Limited Dipper Healthcare Private Limited Group Company Sale of goods or services 5000000 Approved 2728000 0 0
3 Pudumjee Paper Product Limited Quality Tissue Converting Company Private Limited Group Company Any other transaction Purchase and Job work charges 300000000 Approved 45066000 5374000 8017000
4 Pudumjee Paper Product Limited Dipper Healthcare Private Limited Group Company Any other transaction Purchase and Job work charges 200000000 Approved 12078000 4268000 2537000
5 Pudumjee Paper Product Limited Quality Tissue Converting Company Private Limited Group Company Any other transaction Inter-corporate deposit repaid 50000000 Approved 4000000 7400000 3400000 Inter-corporate deposit 0.1125 Continuous Arranegement Unsecured For Working Capital
6 Pudumjee Paper Product Limited Dipper Healthcare Private Limited Group Company Any other transaction Inter-corporate deposit -Given 50000000 Approved 11850000 0 11350000 Inter-corporate deposit 0.1125 Continuous Arranegement Unsecured For Working Capital
7 Pudumjee Paper Product Limited Dipper Healthcare Private Limited Group Company Any other transaction Inter-corporate deposit repaid 50000000 Approved 500000 0 11350000 Inter-corporate deposit 0.1125 Continuous Arranegement Unsecured For Working Capital
8 Pudumjee Paper Product Limited Quality Tissue Converting Company Private Limited Group Company Any other transaction Interest charged on ICD given 411000 Approved 411000 431000 0
9 Pudumjee Paper Product Limited Dipper Healthcare Private Limited Group Company Any other transaction Interest charged on ICD given 310000 Approved 310000 0 0
10 Pudumjee Paper Product Limited 3P Land Holding Limited Group Company Any other transaction Marketing services received 15000000 Approved 8850000 0 0
11 Pudumjee Paper Product Limited AMJ Land Holdings Limited Group Company Any other transaction Lease Rent Paid 10391000 Approved 10391000 0 0
12 Pudumjee Paper Product Limited 3P Land Holdings Limited Group Company Any other transaction Lease Rent Paid 1487000 Approved 1487000 0 0
13 Pudumjee Paper Product Limited AMJ Land Developers Group Entity Any other transaction Lease Rent Received 390000 Approved 390000 34000 0
14 Pudumjee Paper Product Limited Mr.A.K. Jatia Key Management Personnel Remuneration 47316000 Approved 47316000 0 27533000
15 Pudumjee Paper Product Limited Mr.V.P. Leekha Key Management Personnel Remuneration 870000 Approved 870000 0 0
16 Pudumjee Paper Product Limited Dr.Ashok Kumar Key Management Personnel Remuneration 8963000 Approved 8963000 0 0
17 Pudumjee Paper Product Limited Mr.H.P.Birla Key Management Personnel Remuneration 1516000 Approved 1516000 0 0
18 Pudumjee Paper Product Limited Mr.Shrihari Waychal Key Management Personnel Remuneration 643000 Approved 643000 0 0
19 Pudumjee Paper Product Limited Ms. Vrinda Jatia Relative of Key Management Personnel Remuneration 3642000 Approved 3642000 0 0
20 Pudumjee Paper Product Limited Mr. Basant Kumar Khaitan Independent Director Any other transaction Directors Sitting Fees 167000 Approved 167000 0 0
21 Pudumjee Paper Product Limited Mrs. Madhu Dubhashi Independent Director Any other transaction Directors Sitting Fees 165000 Approved 165000 0 0
22 Pudumjee Paper Product Limited Mr. Nandan Damani Independent Director Any other transaction Directors Sitting Fees 167000 Approved 167000 0 0
23 Pudumjee Paper Product Limited Mr. Ved Prakash Leekha Non Executive - Director Any other transaction Directors Sitting Fees 162000 Approved 162000 0 0
24 Pudumjee Paper Product Limited Mr. Vinod Kumar Beswal Independent Director Any other transaction Directors Sitting Fees 165000 Approved 165000 0 0
25 Pudumjee Paper Product Limited Mr.Dilip Jayantilal Thakkar Independent Director Any other transaction Directors Sitting Fees 105000 Approved 105000 0 0
26 Pudumjee Paper Product Limited Mr. Sanjay Kumar Singh Independent Director Any other transaction Directors Sitting Fees 105000 Approved 105000 0 0
27 Pudumjee Paper Product Limited AMJ Land Holdings Limited Group Company Any other transaction Reimbursement of common services -Charged 2500000 Approved 1656000 0 0
28 Pudumjee Paper Product Limited 3P Land Holding Limited Group Company Any other transaction Reimbursement of common services -Charged 1500000 Approved 326000 0 0
29 Pudumjee Paper Product Limited Biodegradable Products India Limited Group Company Any other transaction Reimbursement of common services -Charged 500000 Approved 153000 0 0
30 Pudumjee Paper Product Limited Pudumjee Pulp & Paper Mill Limited Office Staff Provident Fund Entity where KMP have control Any other transaction Towards reimbursement of loss incurred upto current year by Office Staff Provident Fund (Recognised Trust) 983000 Approved 983000 0 0
31 Pudumjee Paper Product Limited Pudumjee Pulp & Paper Mill Limited Office Staff Provident Fund Entity where KMP have control Any other transaction Refund towards temporarily loan from Office Staff Provident Fund (Recognised Trust) 1980000 Approved 1980000 12085000 2270000
32 Pudumjee Paper Product Limited M.P.Jatia Charitable Trust Entities where KMP have Significant Influence Any other transaction Donation Given 5030000 Approved 5030000 0 0
33 Pudumjee Paper Product Limited Shashidevi Mansingka Relative of Key Management Personnel Any other transaction Interest on Deposit Accepted 713000 Approved 713000 16140000 16491000
34 Pudumjee Paper Product Limited Vasudha Jatia Trust Entities where KMP have Significant Influence Any other transaction Interest on Deposit Accepted 261000 Approved 261000 10000000 6000000
35 Pudumjee Paper Product Limited Vrinda Jatia Trust Entities where KMP have Significant Influence Any other transaction Interest on Deposit Accepted 239000 Approved 239000 8000000 6000000
36 Pudumjee Paper Product Limited Ashok Kumar Key Management Personnel Any other transaction Interest on Deposit Accepted 263000 Approved 263000 3410000 3798000
37 Pudumjee Paper Product Limited Shipra Kumar Relative of Key Management Personnel Any other transaction Interest on Deposit Accepted 48000 Approved 48000 620000 689000
38 Pudumjee Paper Product Limited Vasudha Jatia Trust Entities where KMP have Significant Influence Any other transaction Repayment of Deposit Accepted 4000000 Approved 4000000 10000000 6000000
39 Pudumjee Paper Product Limited Vrinda Jatia Trust Entities where KMP have Significant Influence Any other transaction Repayment of Deposit Accepted 2000000 Approved 2000000 8000000 6000000
40 Pudumjee Paper Product Limited 3P Land Holding Limited Group Company Any other transaction Continuing Corporate Financial Gurantee up to Rs. 180 crore (31-Mar-24: Rs. 180 crore) is given to consortium of banks for credit facilities granted to Pudumjee Paper Products Limited * 1800000000 Approved 0 0 0
Total value of transaction during the reporting period 179762000